4 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide (Mounjaro) In Sherman Oaks

If side effects are debilitating, your healthcare provider may suggest staying at a lower dose for a longer period

These tests might include an electrocardiogram (ECG) to check your hearts electrical activity, blood tests to look for markers of heart damage, and imaging tests like a chest X-ray or CT scan

Through manufacturer direct-to-consumer programs, that suggests a range of approximately $349 to $499 per month , consistent with Lilly's current pricing strategy for Zepbound through LillyDirect

Do not take semaglutide if you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)

I love their company and the results from the treatment they provide

Roughly 70 percent of American adults are considered overweight or obese by body mass index, according to the FDA